Clinical Trials Browser

Bronchial Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT01351415 2017-09-18

A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

Phase 3 Completed

485 enrolled 15 charts

Thoracic

Non-Squamous Non-Small Cell Lung Cancer

NCT01360554 2017-05-24

ARCHER 1009

Phase 3 Completed

878 enrolled 24 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00412217 2016-11-25

A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer

Phase 3 Terminated

94 enrolled 6 charts

Head & Neck

Head and Neck Neoplasms

NCT01328951 2016-10-28

A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy

Phase 3 Completed

643 enrolled 16 charts

Thoracic

Non-Squamous Non-Small Cell Lung Cancer

NCT00883779 2015-12-14

A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Phase 3 Completed

451 enrolled 23 charts

Thoracic

Non-Squamous Non-Small Cell Lung Cancer

NCT00738881 2015-10-29

MARVEL

Phase 3 Terminated

23 enrolled 4 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00373425 2015-09-17

RADIANT

Phase 3 Completed

1,252 enrolled 24 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01183858 2015-08-19

A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS)

Phase 3 Completed

315 enrolled 15 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01342965 2015-02-24

A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations

Phase 3 Completed

217 enrolled 11 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00556322 2015-02-23

A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Completed

424 enrolled 29 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00556712 2015-02-11

A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Completed

889 enrolled 43 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00718315 2015-01-15

A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash.

Phase 3 Completed

201 enrolled 16 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00457392 2013-10-29

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

Phase 3 Completed

960 enrolled 13 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00673049 2013-07-24

NSCLC

Phase 3 Terminated

583 enrolled 11 charts

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell